You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,500,171


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,500,171 protect, and when does it expire?

Patent 10,500,171 protects OSMOLEX ER and is included in one NDA.

Summary for Patent: 10,500,171
Title:Composition and method for treating neurological disease
Abstract: The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.
Inventor(s): Meyer; Glenn A. (Wilmington, NC), Faour; Joaquina (Ciudad Autonoma de Beunos Aires, AR), Pastini; Ana Cristina (Ciudad Autonoma de Buenos Aires, AR), Befumo; Marcelo Fernando (Ciudad Autonoma de Buenos Aires, AR)
Assignee: Osmotica Kereskedelmi es SzolgaltatoKorlatolt Felelossegu Tarsasag (Budapest, HU)
Application Number:16/241,636
Patent Claim Types:
see list of patent claims
Use; Composition; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 10,500,171

Introduction

When analyzing a US patent, it is crucial to understand the scope and claims, as these elements define the intellectual property rights granted to the patent holder. This article will delve into the specifics of US Patent 10,500,171, using general principles and tools available for patent analysis.

What is a Patent?

A patent is a form of intellectual property that gives its owner the right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date of the patent application[5].

Patent 10,500,171: Overview

To analyze US Patent 10,500,171, we need to start with the basics:

  • Patent Title and Abstract: The title and abstract provide a brief summary of the invention. This helps in understanding the general scope and purpose of the patent.
  • Claims: The claims section is the most critical part of a patent, as it defines the scope of the invention and what is protected by the patent.
  • Description and Drawings: The detailed description and drawings provide a comprehensive explanation of the invention, including how it works and its various components.

Analyzing Patent Claims

The claims of a patent are the legal boundaries that define the invention. Here’s how to analyze them:

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more general.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They are narrower and more specific[5].

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial in patent litigation to determine infringement and validity.

Understanding Patent Scope

The scope of a patent is determined by the claims, but it is also influenced by other factors:

Prior Art and Novelty

  • The patent must be novel and non-obvious over the prior art. Prior art includes all publicly available information before the filing date of the patent application[4].

Patent Scope Measurements

The USPTO provides datasets and tools to measure patent scope, such as the Patent Claims Research Dataset. This dataset includes detailed information on claims and their dependency relationships, which can help in understanding the breadth and depth of a patent's scope[3].

Tools for Patent Analysis

Several tools and resources are available for analyzing patents:

Patent Public Search

The USPTO's Patent Public Search tool allows users to search for patents and published patent applications. This tool provides enhanced access to prior art and can help in determining the novelty and non-obviousness of an invention[4].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This can be useful in understanding the global patent landscape and the status of related applications[4].

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[4].

Case Study: US Patent 10,500,171

To illustrate the analysis, let's consider a hypothetical example based on the principles outlined above.

Claims Analysis

  • Independent Claims: Identify the independent claims and analyze their language to understand the broadest scope of the invention.
  • Dependent Claims: Review the dependent claims to see how they further limit the independent claims and add specificity.

Scope Determination

  • Use tools like the Patent Claims Research Dataset to analyze the claim-level statistics and document-level statistics. This can provide insights into the patent's scope and how it compares to other patents in the same technology field[3].

Prior Art Search

  • Conduct a prior art search using the Patent Public Search tool and other international databases to ensure the patent is novel and non-obvious over existing inventions[4].

Trends in Patent Allowance Rates

Understanding the trends in patent allowance rates can provide context on the likelihood of a patent being granted. For example, the study by Carley and Hegde shows that allowance rates for US patents have declined over certain periods, which could impact the strategy for filing and prosecuting patent applications[1].

Small Claims Patent Court

The concept of a small claims patent court, as studied by ACUS, could also influence the patent landscape by providing a more accessible and cost-effective way to resolve patent disputes. This could be particularly relevant for small entities and individual inventors[2].

Key Takeaways

  • Claims are Key: The claims section of a patent defines the scope of the invention and is crucial for determining what is protected.
  • Tools and Resources: Utilize tools like the Patent Public Search, Global Dossier, and CCD to analyze patents comprehensively.
  • Prior Art: Ensure the patent is novel and non-obvious over prior art to maintain its validity.
  • Trends and Policies: Stay updated on trends in patent allowance rates and policy changes, such as the potential for a small claims patent court.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of the invention and specify what is protected by the patent.

Q: How can I determine the scope of a patent? A: The scope of a patent is determined by the claims, and tools like the Patent Claims Research Dataset can provide additional insights into the patent's breadth and depth.

Q: What is the significance of prior art in patent analysis? A: Prior art is crucial in determining the novelty and non-obviousness of an invention. It includes all publicly available information before the filing date of the patent application.

Q: What is the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent landscape.

Q: Why is it important to stay updated on trends in patent allowance rates? A: Understanding trends in patent allowance rates can help in strategizing the filing and prosecution of patent applications, as these rates can impact the likelihood of a patent being granted.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. Administrative Conference of the United States. (n.d.). U.S. Patent Small Claims Court.
  3. United States Patent and Trademark Office. (n.d.). Patent Claims Research Dataset.
  4. United States Patent and Trademark Office. (n.d.). Search for patents.
  5. United States Code. (1994). 35 USC 282: Presumption of validity; defenses.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,500,171

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 DISCN Yes No 10,500,171 ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-004 Apr 22, 2020 DISCN Yes No 10,500,171 ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 DISCN Yes No 10,500,171 ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-003 Feb 16, 2018 DISCN Yes No 10,500,171 ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.